These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 29688031)
21. SOX17 is a highly sensitive and specific marker for metastatic ovarian and endometrial carcinomas in cytology cell block specimens. Satturwar S; Shaker N; Sinclair W; Shen R; Parwani AV; Ding Q; Li Z Cancer Cytopathol; 2023 Jul; 131(7):465-470. PubMed ID: 37195085 [TBL] [Abstract][Full Text] [Related]
22. [Origin of ovarian epithelial inclusions and its relationship with the development of low-grade serous carcinoma]. Xiang L; Li J; Wang LJ; Zheng WX; Kong BH Zhonghua Fu Chan Ke Za Zhi; 2011 Oct; 46(10):729-35. PubMed ID: 22321344 [TBL] [Abstract][Full Text] [Related]
23. GATA3 Positivity in Benign Radiated Prostate Glands: A Potential Diagnostic Pitfall. Wobker SE; Khararjian A; Epstein JI Am J Surg Pathol; 2017 Apr; 41(4):557-563. PubMed ID: 28291125 [TBL] [Abstract][Full Text] [Related]
24. New Challenges in the Differential Diagnosis of High-Grade Triple-Negative Breast Cancer and Serous Carcinoma. Puzyrenko A; Cortina CS; Jorns JM Int J Surg Pathol; 2022 Oct; 30(7):728-733. PubMed ID: 35234527 [TBL] [Abstract][Full Text] [Related]
25. Evaluation of cell blocks from effusion specimens in Gynecologic Oncopathology: An experience of 220 cases, diagnosed at a Tertiary Cancer Referral Center. Rekhi B; Karmarkar S; Gupta C; Deodhar KK; Menon S; Pathuthara S; Maheshwari A; Shylasree TS; Gupta S Indian J Pathol Microbiol; 2020; 63(3):427-434. PubMed ID: 32769333 [TBL] [Abstract][Full Text] [Related]
26. Young investigator challenge: The utility of GATA3 immunohistochemistry in the evaluation of metastatic breast carcinomas in malignant effusions. Lew M; Pang JC; Jing X; Fields KL; Roh MH Cancer Cytopathol; 2015 Oct; 123(10):576-81. PubMed ID: 26465236 [TBL] [Abstract][Full Text] [Related]
27. Low-grade ovarian serous neoplasms (low-grade serous carcinoma and serous borderline tumor) associated with high-grade serous carcinoma or undifferentiated carcinoma: report of a series of cases of an unusual phenomenon. Boyd C; McCluggage WG Am J Surg Pathol; 2012 Mar; 36(3):368-75. PubMed ID: 22082603 [TBL] [Abstract][Full Text] [Related]
28. The role of GATA binding protein 3 in the differential diagnosis of collecting duct and upper tract urothelial carcinomas. Gonzalez-Roibon N; Albadine R; Sharma R; Faraj SF; Illei PB; Argani P; Ertoy D; Allaf ME; Netto GJ Hum Pathol; 2013 Dec; 44(12):2651-7. PubMed ID: 24071011 [TBL] [Abstract][Full Text] [Related]
29. Immunohistochemical Differentiation of Plasmacytoid Urothelial Carcinoma From Secondary Carcinoma Involvement of the Bladder. Borhan WM; Cimino-Mathews AM; Montgomery EA; Epstein JI Am J Surg Pathol; 2017 Nov; 41(11):1570-1575. PubMed ID: 28786878 [TBL] [Abstract][Full Text] [Related]
30. CDX2, SATB2, GATA3, TTF1, and PAX8 Immunohistochemistry in Krukenberg Tumors. Chiesa-Vottero A Int J Gynecol Pathol; 2020 Mar; 39(2):170-177. PubMed ID: 32045390 [TBL] [Abstract][Full Text] [Related]
31. The diagnostic utility of the triple markers Napsin A, TTF-1, and PAX8 in differentiating between primary and metastatic lung carcinomas. El-Maqsoud NM; Tawfiek ER; Abdelmeged A; Rahman MF; Moustafa AA Tumour Biol; 2016 Mar; 37(3):3123-34. PubMed ID: 26427663 [TBL] [Abstract][Full Text] [Related]
32. Simultaneous carcinomas of the breast and ovary: utility of Pax-8, WT-1, and GATA3 for distinguishing independent primary tumors from metastases. Espinosa I; Gallardo A; D'Angelo E; Mozos A; Lerma E; Prat J Int J Gynecol Pathol; 2015 May; 34(3):257-65. PubMed ID: 25844549 [TBL] [Abstract][Full Text] [Related]
33. High-grade serous ovarian carcinoma with mucinous differentiation: report of a rare and unique case suggesting transition from the "SET" feature of high-grade serous carcinoma to the "STEM" feature. Hatano Y; Tamada M; Asano N; Hayasaki Y; Tomita H; Morishige KI; Hara A Diagn Pathol; 2019 Jan; 14(1):4. PubMed ID: 30636633 [TBL] [Abstract][Full Text] [Related]
34. Malignant ascites occurs most often in patients with high-grade serous papillary ovarian cancer at initial diagnosis: a retrospective analysis of 191 women treated at Bayreuth Hospital, 2006-2015. Krugmann J; Schwarz CL; Melcher B; Sterlacci W; Ozalinskaite A; Lermann J; Agaimy A; Vieth M Arch Gynecol Obstet; 2019 Feb; 299(2):515-523. PubMed ID: 30415435 [TBL] [Abstract][Full Text] [Related]
35. Undifferentiated Carcinoma of the Endometrium: An Expanded Immunohistochemical Analysis Including PAX-8 and Basal-Like Carcinoma Surrogate Markers. Ramalingam P; Masand RP; Euscher ED; Malpica A Int J Gynecol Pathol; 2016 Sep; 35(5):410-8. PubMed ID: 26598976 [TBL] [Abstract][Full Text] [Related]
36. SALL4 expression in germ cell and non-germ cell tumors: a systematic immunohistochemical study of 3215 cases. Miettinen M; Wang Z; McCue PA; Sarlomo-Rikala M; Rys J; Biernat W; Lasota J; Lee YS Am J Surg Pathol; 2014 Mar; 38(3):410-20. PubMed ID: 24525512 [TBL] [Abstract][Full Text] [Related]
37. GATA3 Expression in Common Gynecologic Carcinomas: A Potential Pitfall. Terzic T; Mills AM; Zadeh S; Atkins KA; Hanley KZ Int J Gynecol Pathol; 2019 Sep; 38(5):485-492. PubMed ID: 30059453 [TBL] [Abstract][Full Text] [Related]
38. Ovarian Brenner tumors and Walthard nests: a histologic and immunohistochemical study. Roma AA; Masand RP Hum Pathol; 2014 Dec; 45(12):2417-22. PubMed ID: 25281026 [TBL] [Abstract][Full Text] [Related]
39. A comprehensive analysis of PAX8 expression in human epithelial tumors. Laury AR; Perets R; Piao H; Krane JF; Barletta JA; French C; Chirieac LR; Lis R; Loda M; Hornick JL; Drapkin R; Hirsch MS Am J Surg Pathol; 2011 Jun; 35(6):816-26. PubMed ID: 21552115 [TBL] [Abstract][Full Text] [Related]
40. PAX8 expression in uterine adenocarcinomas and mesonephric proliferations. Yemelyanova A; Gown AM; Wu LS; Holmes BJ; Ronnett BM; Vang R Int J Gynecol Pathol; 2014 Sep; 33(5):492-9. PubMed ID: 25083965 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]